SAB BIOTHERAPEUTICS, INC.

SABS ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2025

Total Assets: $172.8M

Liabilities Breakdown FY2025

Total Liabilities: $21.3M